Sodium Valproate 134 Mg + Valproic Acid 58 Mg Cr

Sodium Valproate 134 Mg + Valproic Acid 58 Mg CR (controlled relese) tablet is typically prescribed for the treatment of seizure disorders, including epilepsy. It helps control seizures by stabilizing electrical activity in the brain. Sodium Valproate 134 Mg + Valproic Acid 58 Mg CR (controlled release) tablet slows down electrical signals in the brain which cause seizures (fits). It can also help reduce symptoms such as confusion, uncontrollable jerking movements, loss of awareness, and fear or anxiety.

Swallow the delayed-release capsules or oral capsules whole with a full glass of water. Do not split, crush, or chew it. You may take this medicine with food to decrease stomach upset.

Store the mediciner at room temperature, away from heat, moisture, and direct light.

Side effects may include abdominal pain, alopecia, amblyopia/blurred vision, amnesia, anorexia, asthenia, nausea, and insomnia.

Avoid use of this drug during pregnancy, Evidence has demonstrated fetal abnormalities or risks when used during pregnancy. Advise women of childbearing potential of fetal risk.

Using this medicine while you are pregnant (especially during the first 3 months of pregnancy) can harm your unborn baby and cause serious unwanted effects Valproic acid may cause serious allergic reactions affecting multiple body organs (e.g., liver or kidney). Valproic acid may cause some people to become dizzy, lightheaded, drowsy, or less alert than they are normally. Do not stop using this medicine without first checking with your doctor. Your doctor may want you to gradually reduce the amount you are using before stopping completely. patient to avoid activities requiring mental alertness or coordination until drug effects are realized, as drug may cause drowsiness.

Klotz U & Antonin KH: Pharmacokinetics and bioavailability of sodium valproate. Clin Pharmacol Ther 1977; 21:736-743. Product Information: Depakine Chrono oral tablet, sodium valproate and valproic acid oral tablet. Sanofi-Aventis France (per SFDA; Saudi Arabia), 2018.

Sodium Valproate and Valproic Acid: They work by increasing the levels of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits brain activity. By enhancing GABA levels, these medications help to stabilize electrical activity in the brain, thereby reducing the likelihood of seizures.

Anti-convulsant.